Intuitive Surgical, Inc. vs Texas Instruments Incorporated — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Texas Instruments Incorporated trades at $283.74 (market cap $263.20B). The key difference: Texas Instruments Incorporated is the larger of the two by market cap, and Texas Instruments Incorporated pays a 2.11% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Texas Instruments Incorporated for 76 Days on average.
| ISRG | TXN | |
|---|---|---|
Market Cap | $146.76B | $263.20B |
Volume | 2,529,814 | 5,850,256 |
Sector | Health | Technology |
52-Week High | $592.85 | $332.35 |
52-Week Low | $332.02 | $153.33 |
Typical Hold Time | 84 Days | 76 Days |
Enterprise Value | $141.54B | $270.25B |
Dividend Yield | — | 2.11% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.80, and has shown consistent revenue growth, reaching $10.06B in 2025. Analyst consensus is strongly bullish with a $480.78 price target, though the stock faces headwinds from slower procedure growth in some markets.
The outlook for ISRG remains positive due to its dominant position in robotic surgery, expanding international presence, and high recurring revenue. Key risks include competitive pressures, regulatory hurdles, and economic sensitivity affecting procedure volumes. With solid fundamentals and analyst support, the stock offers growth potential, but investors should monitor execution against these risks.
Texas Instruments (TXN) trades at $288.20, down 0.26% on the day, with strong technical momentum showing bullish moving averages and key support at $284. The company demonstrates robust fundamentals with 31.11% net margins and 34.97% ROE, though valuation ratios remain elevated with a P/E of 43.8. Recent earnings show mixed results with Q1 and Q2 2026 beats but a Q4 2025 miss, while data center sales growth and dividend payments highlight ongoing shareholder returns.
Outlook remains positive with analyst consensus targeting $325 (13% upside) amid accelerating revenue growth and AI-driven demand. Key risks include premium valuation sensitivity, cyclical semiconductor exposure, and rising debt levels. Institutional sentiment is bullish with 48% buy ratings, supported by strong cash flow generation and strategic positioning in industrial and data center markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Read more on TXN →